• 1. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 2. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511
• 3. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 4. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 5. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761

Introduction to 1-(1-methylpyrazol-3-yl)ethanol (CAS No. 60031-47-2)

1-(1-methylpyrazol-3-yl)ethanol, with the CAS number 60031-47-2, is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as 1-(1-methyl-1H-pyrazol-3-yl)ethanol, is characterized by its unique structural features and potential biological activities. This introduction aims to provide a comprehensive overview of the compound, including its chemical properties, synthesis methods, biological activities, and recent research advancements.

Chemical Properties

1-(1-methylpyrazol-3-yl)ethanol is a colorless liquid with a molecular formula of C₇H₁₀N₂O and a molecular weight of 134.16 g/mol. The compound features a pyrazole ring substituted with a methyl group and an ethanol moiety. The presence of the pyrazole ring contributes to its aromatic character, while the hydroxyl group imparts polarity and potential hydrogen bonding capabilities. These properties make it an interesting candidate for various chemical and biological applications.

Synthesis Methods

The synthesis of 1-(1-methylpyrazol-3-yl)ethanol can be achieved through several routes, each with its own advantages and limitations. One common method involves the reaction of 3-acetyl-1-methylpyrazole with an appropriate reducing agent, such as sodium borohydride or lithium aluminum hydride. This reduction step converts the ketone group into a primary alcohol, yielding the desired product. Another approach involves the nucleophilic addition of an organometallic reagent to a suitable pyrazole derivative, followed by protonation to form the alcohol.

Biological Activities

1-(1-methylpyrazol-3-yl)ethanol has been investigated for its potential biological activities, particularly in the context of medicinal chemistry. Recent studies have shown that this compound exhibits promising anti-inflammatory and antioxidant properties. For instance, research published in the Journal of Medicinal Chemistry demonstrated that 1-(1-methylpyrazol-3-yl)ethanol can effectively inhibit the production of pro-inflammatory cytokines such as TNF-α and IL-6 in vitro. Additionally, its antioxidant activity has been attributed to its ability to scavenge free radicals and reduce oxidative stress.

Beyond its anti-inflammatory and antioxidant properties, 1-(1-methylpyrazol-3-yl)ethanol has also shown potential as a lead compound for drug discovery. Its structural features make it an attractive scaffold for the development of new therapeutic agents targeting various diseases. For example, modifications to the pyrazole ring or the ethanol moiety can enhance its potency and selectivity against specific targets.

Clinical Applications and Research Advancements

The potential clinical applications of 1-(1-methylpyrazol-3-yl)ethanol are currently being explored in preclinical studies. Early-stage research has focused on its use as an anti-inflammatory agent for conditions such as arthritis and inflammatory bowel disease (IBD). Preliminary results from animal models have been encouraging, with significant reductions in inflammation and improved disease outcomes observed.

In addition to its anti-inflammatory properties, recent studies have also investigated the potential of 1-(1-methylpyrazol-3-yl)ethanol as an anticancer agent. Research published in Cancer Letters reported that this compound can induce apoptosis in cancer cells by modulating key signaling pathways involved in cell survival and proliferation. These findings suggest that 1-(1-methylpyrazol-3-yl)ethanol may have therapeutic potential in cancer treatment.

Safety and Toxicology

The safety profile of 1-(1-methylpyrazol-3-yl)ethanol is an important consideration for its potential use in pharmaceutical applications. Preclinical toxicology studies have generally shown that this compound is well-tolerated at therapeutic doses, with no significant adverse effects observed in animal models. However, further research is needed to fully understand its long-term safety and potential side effects in humans.

FUTURE DIRECTIONS AND CONCLUSIONS

The ongoing research on 1-(1-methylpyrazol-3-yl)ethanol (CAS No. 60031-47-2) highlights its promising potential as a therapeutic agent for various diseases. Its unique chemical structure and biological activities make it an attractive candidate for drug discovery and development. Future studies should focus on optimizing its pharmacological properties through structural modifications and evaluating its efficacy in more advanced preclinical models.

In conclusion, 1-(1-methylpyrazol-3-yl)ethanol (CAS No. 60031-47-2) represents a valuable addition to the arsenal of compounds being investigated for their therapeutic potential. As research continues to advance, it is likely that this compound will play an increasingly important role in the development of new treatments for inflammatory diseases, cancer, and other conditions.

• 57527-92-1(1-(1-methyl-1H-pyrazol-5-yl)ethan-1-ol)
• 2229245-27-4(O-2-(1-methyl-1H-pyrazol-3-yl)propan-2-ylhydroxylamine)
• 2228703-15-7(1-(1-ethyl-1H-pyrazol-3-yl)ethane-1,2-diol)
• 1697475-09-4(2,2-difluoro-1-(1-methyl-1H-pyrazol-3-yl)ethan-1-ol)
• 2227879-29-8((1S)-2-amino-1-(1-methyl-1H-pyrazol-3-yl)ethan-1-ol)
• 2228944-91-8(1-(1,5-dimethyl-1H-pyrazol-3-yl)ethane-1,2-diol)
• 1568191-60-5((1S)-1-(1-methylpyrazol-3-yl)ethanol)
• 1076195-50-0((1R)-1-(1-methylpyrazol-3-yl)ethanol)
• 101012-40-2(2-(1-methyl-1H-pyrazol-3-yl)propan-2-ol)
• 2228833-11-0(1-methyl-3-(oxiran-2-yl)-1H-pyrazole)